| Title |
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
|
|---|---|
| Published in |
PharmacoEconomics, September 2012
|
| DOI | 10.2165/11586560-000000000-00000 |
| Pubmed ID | |
| Authors |
Naiyana Praditsitthikorn, Yot Teerawattananon, Sripen Tantivess, Supon Limwattananon, Arthorn Riewpaiboon, Saibua Chichareon, Nantakan Ieumwananonthachai, Viroj Tangcharoensathien |
| Abstract |
The Thai healthcare setting has seen patients with cervical cancer experience an increasing burden of morbidity and mortality, a stagnation in the performance of cervical screening programmes and the introduction of a vaccine for the prevention of human papillomavirus (HPV) infection. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| United Kingdom | 1 | <1% |
| Thailand | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 186 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 18% |
| Student > Master | 33 | 17% |
| Student > Ph. D. Student | 18 | 9% |
| Student > Postgraduate | 16 | 8% |
| Student > Doctoral Student | 13 | 7% |
| Other | 28 | 15% |
| Unknown | 49 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 32% |
| Economics, Econometrics and Finance | 19 | 10% |
| Nursing and Health Professions | 11 | 6% |
| Social Sciences | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Other | 26 | 14% |
| Unknown | 55 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2020.
All research outputs
#2,759,731
of 25,373,627 outputs
Outputs from PharmacoEconomics
#236
of 1,991 outputs
Outputs of similar age
#19,190
of 189,935 outputs
Outputs of similar age from PharmacoEconomics
#30
of 550 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,935 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 550 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.